| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-849 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-61 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-16 |
| filingDate |
1987-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03e812ce2111a6602cec6a323966c9e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02353c2d0010ece38c0bb04e2b329048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91c6aefbd2792463cc521400ce9b6cf1 |
| publicationDate |
1992-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MY-102555-A |
| titleOfInvention |
An improved derivative of the tryptophan operon for expression of fused gene products |
| abstract |
THE PRESENT INVENTION COMPRISES IMPROVED DERIVATIVES OF THE TRYPTOPHAN OPERON USEFUL FOR EXPRESSING FUSED GENE PRODUCTS IN @E. COLI AND RELATED ORGANISMS. TWO OF THE IMPROVED DERIVATIES DISCLOSED ARE ENCODED ON 0.43 AND 0.55 KB ECORI RESTRICTION FRAGMENTS FROM PLASMIDS PCZ20 AND PLEBGH2 (NRRL B - 15881 AND NRRL B - 15882), RESPECTIVELY. THE MODIFIED DERIVATIVES HAVE BEEN PLACED ON RECOMBINANT DNACLONING AND EXPRESSION VECTORS. A VARIETY OF EXPRESSION VECTORS HAVE BEEN CONSTRUCTED THAT DRIVE EXPRESSION OF FUSED GENE PRODUCTS. TWO NOVEL GENE SEQUENCE, ECODING INSULIN - LIKE GROWTH FACTORS I AND II, HAVE BEEN EXPRESSED WITH THE MODIFIED TRYPTOPHAN OPERON SYSTEM.@@(FIG. 1)@ |
| priorityDate |
1984-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |